YU49427B - Mikročestice derivata tetrahidropiridina - Google Patents

Mikročestice derivata tetrahidropiridina

Info

Publication number
YU49427B
YU49427B YU28899A YU28899A YU49427B YU 49427 B YU49427 B YU 49427B YU 28899 A YU28899 A YU 28899A YU 28899 A YU28899 A YU 28899A YU 49427 B YU49427 B YU 49427B
Authority
YU
Yugoslavia
Prior art keywords
microparticles
tetrahydropyridin
derivatives
dependent
50vμm
Prior art date
Application number
YU28899A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU28899A (sh
Inventor
Antoine Caron
Jean-Pierre Chambon
Olivier Monnier
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of YU28899A publication Critical patent/YU28899A/sh
Publication of YU49427B publication Critical patent/YU49427B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
YU28899A 1996-12-23 1997-12-23 Mikročestice derivata tetrahidropiridina YU49427B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615905A FR2757510B1 (fr) 1996-12-23 1996-12-23 Forme microparticulaire d'un derive de tetrahydropyridine

Publications (2)

Publication Number Publication Date
YU28899A YU28899A (sh) 2000-03-21
YU49427B true YU49427B (sh) 2006-01-16

Family

ID=9499044

Family Applications (1)

Application Number Title Priority Date Filing Date
YU28899A YU49427B (sh) 1996-12-23 1997-12-23 Mikročestice derivata tetrahidropiridina

Country Status (37)

Country Link
US (4) US20020028247A1 (Direct)
EP (1) EP0950051B1 (Direct)
JP (2) JP4422214B2 (Direct)
KR (1) KR100455797B1 (Direct)
CN (1) CN1088698C (Direct)
AR (1) AR009673A1 (Direct)
AT (1) ATE250032T1 (Direct)
AU (1) AU730302B2 (Direct)
BR (1) BR9714177A (Direct)
CA (1) CA2275593C (Direct)
CO (1) CO4920213A1 (Direct)
CZ (1) CZ294272B6 (Direct)
DE (1) DE69724999T2 (Direct)
DK (1) DK0950051T3 (Direct)
DZ (1) DZ2386A1 (Direct)
EE (1) EE04112B1 (Direct)
EG (1) EG24749A (Direct)
ES (1) ES2207758T3 (Direct)
FR (1) FR2757510B1 (Direct)
HU (1) HU224348B1 (Direct)
IL (1) IL129937A (Direct)
IN (1) IN186977B (Direct)
IS (1) IS2064B (Direct)
MY (1) MY126298A (Direct)
NO (1) NO311569B1 (Direct)
NZ (1) NZ336129A (Direct)
PL (1) PL190098B1 (Direct)
PT (1) PT950051E (Direct)
RU (1) RU2193031C2 (Direct)
SI (1) SI0950051T1 (Direct)
SK (1) SK283917B6 (Direct)
TR (1) TR199901362T2 (Direct)
TW (1) TW534820B (Direct)
UA (1) UA66776C2 (Direct)
WO (1) WO1998028272A1 (Direct)
YU (1) YU49427B (Direct)
ZA (1) ZA9711579B (Direct)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004001A1 (en) * 2001-07-06 2003-01-16 Lifecycle Pharma A/S Controlled agglomeration
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
RU2472490C1 (ru) * 2011-08-05 2013-01-20 Открытое акционерное общество "Биосинтез" Средство для лечения кожных гнойных инфекций, составы и способы получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US562883A (en) * 1896-06-30 Thill-coupling
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
KR100225983B1 (ko) * 1992-10-26 1999-10-15 클라우스-디터 홈메리히, 디트리히 빌헬름 샤흐트 마이크로캡슐의 제조 방법
US5662883A (en) * 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
US6489334B2 (en) * 1996-12-23 2002-12-03 Sanofi-Synthelabo Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors

Also Published As

Publication number Publication date
DE69724999D1 (de) 2003-10-23
IS2064B (is) 2005-11-15
IL129937A (en) 2002-09-12
DZ2386A1 (fr) 2002-12-28
UA66776C2 (uk) 2004-06-15
AU5668598A (en) 1998-07-17
SK82999A3 (en) 1999-12-10
RU2193031C2 (ru) 2002-11-20
SK283917B6 (sk) 2004-05-04
ZA9711579B (en) 1998-06-25
US20080255365A1 (en) 2008-10-16
PL190098B1 (pl) 2005-10-31
JP2001507013A (ja) 2001-05-29
ES2207758T3 (es) 2004-06-01
ATE250032T1 (de) 2003-10-15
NO311569B1 (no) 2001-12-10
JP2009280581A (ja) 2009-12-03
DK0950051T3 (da) 2004-01-26
TR199901362T2 (xx) 1999-09-21
CZ294272B6 (cs) 2004-11-10
US20020028247A1 (en) 2002-03-07
HUP0001181A2 (hu) 2000-11-28
AU730302B2 (en) 2001-03-01
FR2757510A1 (fr) 1998-06-26
PT950051E (pt) 2004-02-27
CN1241179A (zh) 2000-01-12
JP4422214B2 (ja) 2010-02-24
KR20000069503A (ko) 2000-11-25
IS5077A (is) 1999-06-10
US20100021541A1 (en) 2010-01-28
YU28899A (sh) 2000-03-21
WO1998028272A1 (fr) 1998-07-02
CA2275593C (en) 2005-12-20
CA2275593A1 (en) 1998-07-02
TW534820B (en) 2003-06-01
CZ229199A3 (cs) 1999-09-15
IL129937A0 (en) 2000-02-29
EE04112B1 (et) 2003-08-15
FR2757510B1 (fr) 2000-01-07
EE9900263A (et) 2000-02-15
HU224348B1 (hu) 2005-08-29
SI0950051T1 (en) 2004-02-29
KR100455797B1 (ko) 2004-11-06
MY126298A (en) 2006-09-29
PL334276A1 (en) 2000-02-14
NZ336129A (en) 2000-11-24
BR9714177A (pt) 2000-02-29
HUP0001181A3 (en) 2003-03-28
IN186977B (Direct) 2001-12-22
NO993077D0 (no) 1999-06-22
HK1024000A1 (en) 2000-09-29
US20020192292A1 (en) 2002-12-19
EP0950051B1 (fr) 2003-09-17
EG24749A (en) 2010-07-20
DE69724999T2 (de) 2004-07-22
AR009673A1 (es) 2000-04-26
NO993077L (no) 1999-06-22
EP0950051A1 (fr) 1999-10-20
CO4920213A1 (es) 2000-05-29
CN1088698C (zh) 2002-08-07

Similar Documents

Publication Publication Date Title
CY1108348T1 (el) Υποκατεστημενα 2-(2,6-διοξοπιπεριδιν-3-υλ)-φθαλιμιδια και μεθοδος μειωσης των tnf αλφα επιπεδων
FI962489A7 (fi) Morfoliini-ja tiomoforfoliinitakykiniinireseptoriantaginisteja
ATE173255T1 (de) 3-(5-tetrazolyl-benzyl) aminopiperidin-derivate und tachykinin antagonisten
IT1319594B1 (it) Apparecchiatura e metodo per l'attivazione ed il controllo delleunita' di smistamento in una macchina smistatrice
EE9600186A (et) Neurokiniini (tahhüülkiniini) antagonistid
DE60029857D1 (de) Lichtempfindliche Zusammensetzung und 1,3-dihydro-1-oxo-2H-Indenderivat
FI971685L (fi) Takykiniini-antagonisteja
TR200202323T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
AU2003293405A8 (en) Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
DE69611315D1 (de) 5-Substituierte-3-(1,2,3,6-Tetrahydropyridin-4-yl) und 3-(Piperidin-4-yl)-1H-indole: 5-HT1F Agonisten
NO990760D0 (no) 1,4-heterocykliske metallproteaseinhibitorer
FI964898A7 (fi) 4-aryyli-1-(indaanimetyyli-, dihydrobentsofuraanimetyyli- tai dihydrobentsotiofeenimetyyli) piperidiinejä, -tetra-hydropyridiinejä tai -piperatsiineja
FI971108A0 (fi) Audiokoodausmenetelmä ja -laite
ATE301329T1 (de) Partikel
EE9700202A (et) Diasendatud 1,4-piperidiini estrid ja amiidid, mis omavad 5-HT4 antagonistlikku aktiivsust
EP0952154A3 (en) N-acyl and N-aroyl aralkyl amides
EP0983958A4 (en) ESCALATOR STAGE AND ESCALATOR
YU49427B (sh) Mikročestice derivata tetrahidropiridina
ID15912A (id) Turunan-turunan 1-(1,2-piperidinil yang didwisubstitusi)-4-(imidazol yang dilebur)-piperidin
DK0888114T3 (da) Anvendelse af (+)-alfa-(2,3-dimethoxyphenyl)-1-[2-(4-flourphenyl)-ethyl]-4-piperidinmethanol til behandling af depressive lidelser og bipolare lidelser
DE69628743D1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
AU2474200A (en) Substituted oximes and hydrazones as neurokinin antagonists
ATE282417T1 (de) Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen
MX9603045A (es) Antagonistas de los receptores endoteliales.
DK1315700T3 (da) Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner